chrX-15331839-C-T
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_002641.4(PIGA):c.92G>A(p.Arg31His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,210,118 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_002641.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIGA | NM_002641.4 | c.92G>A | p.Arg31His | missense_variant | 2/6 | ENST00000333590.6 | NP_002632.1 | |
PIGA | NM_020473.3 | c.13+3662G>A | intron_variant | NP_065206.3 | ||||
PIGA | NR_033835.1 | n.208G>A | non_coding_transcript_exon_variant | 2/6 | ||||
PIGA | NR_033836.1 | n.173+35G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIGA | ENST00000333590.6 | c.92G>A | p.Arg31His | missense_variant | 2/6 | 1 | NM_002641.4 | ENSP00000369820.3 |
Frequencies
GnomAD3 genomes AF: 0.0000268 AC: 3AN: 112033Hom.: 0 Cov.: 23 AF XY: 0.0000292 AC XY: 1AN XY: 34213
GnomAD3 exomes AF: 0.0000600 AC: 11AN: 183473Hom.: 0 AF XY: 0.0000442 AC XY: 3AN XY: 67909
GnomAD4 exome AF: 0.0000219 AC: 24AN: 1098085Hom.: 0 Cov.: 30 AF XY: 0.0000165 AC XY: 6AN XY: 363441
GnomAD4 genome AF: 0.0000268 AC: 3AN: 112033Hom.: 0 Cov.: 23 AF XY: 0.0000292 AC XY: 1AN XY: 34213
ClinVar
Submissions by phenotype
Multiple congenital anomalies-hypotonia-seizures syndrome 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 07, 2023 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2018 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at